Advertisement
Home Blog Page 3602
More than nine out of 10 U.S. children entered kindergarten last school year protected with the proper immunizations

CDC: Most U.S. Children Getting Vaccinated

0
But some states still have exemption rates that exceed national average
A proposal for identifying lower-cost generic biotech drugs has been released by the U.S. Food and Drug Administration.

FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

0
All biotech drugs to carry a four-letter code to distinguish brand name, generic versions
Longer colonoscopy withdrawal time is associated with lower risk for colorectal cancer over five years

Longer Colonoscopy Withdrawal Time May Cut Cancer Risk

0
Viewing time of less than six minutes linked to higher cancer rates
Severe liver damage may be four times more common among Americans with hepatitis C than previously believed

Cirrhosis in Hepatitis C More Widespread Than Thought

0
Biopsy alone greatly underestimates prevalence, researcher says
Microfocused ultrasound appears safe for improving laxity of the skin of the face and neck in patients with Fitzpatrick skin types III to VI

Microfocused Ultrasound Safe for Fitzpatrick Skin Types III-VI

0
Three reported adverse events were temporary and associated with treatment technique
Tadalafil (Cialis) combined with ambrisentan (Letairis) significantly reduces the progression of pulmonary arterial hypertension

Cialis Combo Rx Aids Treatment of Pulmonary Arterial HTN

0
Combining tadalafil, blood pressure med helped patients with pulmonary arterial hypertension
For most atrial fibrillation patients taking warfarin who require temporary interruption for a procedure

Periop Bridging Unnecessary for Most A-Fib Patients on Warfarin

0
Arterial thromboembolism risk doesn't appear to rise without additional drug treatment
Daratumumab monotherapy has a favorable safety profile and encouraging efficacy in patients with heavily pretreated and refractory myeloma in a phase 1-2 trial. The results of the study were published online Aug. 26 in the New England Journal of Medicine.

Daratumumab Monotherapy Promising for Multiple Myeloma

0
Findings in a phase 1-2 study of patients with relapsed myeloma or relapsed/refractory myeloma
The risk of death

Sleep Deprived Surgeons Appear to Be Self-Regulating Well

0
Review indicates that doctors who operate the night before another surgery do well
An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed by computed tomography or magnetic resonance imaging

Blood Test Predicts Relapse in Early-Stage Breast Cancer

0
Circulating tumor DNA analysis spots stray cells months before scans detect recurrence